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Abstract
Aim: To explore the impact of bacterial load and microbial colonization patterns on
the clinical outcomes of periodontal surgery at deep intrabony defects.
Materials and Methods: One hundred and twenty-two patients with advanced
chronic periodontitis and at least one intrabony defect of43 mm were recruited in 10
centres. Before recruitment, the infection control phase of periodontal therapy was
completed. After surgical access and debridement, the regenerative material was
applied in the test subjects, and omitted in the controls. At baseline and 1 year
following the interventions, clinical attachment levels (CAL), pocket probing depths
(PPD), recession (REC), full-mouth plaque scores and full-mouth bleeding scores were
assessed. Microbial colonization of the defect-associated pocket was assessed using a
DNA–DNA checkerboard analysis.
Results: Total bacterial load and counts of red complex bacteria were negatively
associated with CAL gains 1 year following treatment. The probability of achieving
above median CAL gains (43 mm) was significantly decreased by higher total bacterial
counts, higher red complex and T. forsythensis counts immediately before surgery.
Conclusions: Presence of high bacterial load and specific periodontal pathogen
complexes in deep periodontal pockets associated with intrabony defects had a
significant negative impact on the 1 year outcome of surgical/regenerative treatment.
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In spite of the availability of multiple
efficacious techniques and biological
principles, periodontal regeneration of
intrabony defects remains a clinical
challenge (Cortellini & Tonetti 2000,
Trombelli et al. 2002, Needleman et al.
2002, Murphy & Gunsolley 2003). Mul-
tiple recent studies have attempted to
improve outcomes by studying novel
combinations of current materials
(Francetti et al. 2004, Hou et al. 2004,
Vouros et al. 2004, Minenna et al.
2005), or by testing the adjunctive ben-
efits of lasers (Sculean et al. 2004).
Since the seminal work of Rosling et
al. (1976) and Nyman et al. (1977), the
impact of bacterial plaque on healing
after surgical treatment of intrabony
defects has been well recognized. Early
work on regeneration with barrier mem-
branes established a negative associa-
tion between plaque control and clinical
attachment level gain (Tonetti et al.
1993, 1995). Shortly after, Machtei et
al. (1994) reported the detrimental effect
of the persistence of specific periodontal
pathogens in the pockets to be regener-
ated. Several studies have indicated that
bleeding on probing (at the site and
expressed as percentage of bleeding
sites in the mouth of the patient), a
clinical estimation of the persistence of
periodontal pathogens, has a negative
impact on clinical attachment level
(CAL) gain (Tonetti et al. 1993, 1996).
In more recent years, evidence has
expanded and indicates that the presence
of a pathogenic flora at the regenerated
site or in the oral cavity of the patient
before, during or after periodontal
regeneration is associated with sub-opti-
mal outcomes (Nowzari et al. 1995, De
Sanctis et al. 1996, Zucchelli et al. 1997,
Smith MacDonald et al. 1998, Rudiger
et al. 2003). The importance of such
pathogenic flora has been further empha-
sized by studies indicating that suppres-
sion of local microbiota with local
antibiotic delivery at the wound site at
the time of periodontal regeneration
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1994, Zucchelli et al. 1999, Yoshinari et
al. 2001, Stavropoulos et al. 2003).
In a series of multicentre clinical
trials on periodontal regeneration, a sig-
nificant centre effect has been constantly
detected (Tonetti et al. 1998, Cortellini
et al. 2001, Tonetti et al. 2002, Tonetti et
al. 2004). In fact, in these trials centre
variability has been the single most
important factor representing three to
five times the magnitude of the benefit
arising from the application of a specific
regenerative technique. Current hypoth-
eses to explain centre variability include
inconsistency in patient population, clin-
ical setting, clinician experience and
different abilities to suppress the perio-
dontal microflora in the initial, cause-
related phase of periodontal therapy.
This paper reports a secondary ana-
lysis of a randomized controlled clinical
trial designed to compare, in a multi-
centre study, the clinical outcomes
obtained following treatment of intra-
bony defects with papilla preservation
flap surgery with or without application
of a bioresorbable membrane in combi-
nation with a bone replacement graft.
This analysis explores the impact of the
microbial colonization patterns in the
subgingival plaque on the clinical out-
comes 1 year after treatment. Data indi-
cated that counts but not proportions of
periodontal pathogens were significantly
associated with the clinical outcomes.
Material and Methods
Experimental design
This parallel group, randomized, multi-
centre and controlled clinical trial was
designed to compare the efficacy of two
treatment modalities in intrabony perio-
dontal defects. The test treatment con-
sisted of access of the defect with
papilla preservation flaps (Cortellini et
al. 1995, Cortellini et al. 1999), surgical
debridement and application of a bovine
bone replacement graft to overfill the
defect (Bio-Oss
s
, Geistlich AG, Wohl-
husen, Switzerland) and a collagen
membrane, previously adapted to the




AG). The same procedure was per-
formed in the control group except for
the omission of the application of the
regenerative materials. A single defect
was treated in each patient. Clinical
outcomes were evaluated at 1 year.
This investigation was performed at 10
periodontal practices constituting a
practice-based research network. Cen-
tres were located in Belgium, Germany,
Greece, Italy, Switzerland, the United
Kingdom and the United States of
America. Details of the experimental
design, calibration, randomization, sur-
gical procedures and post-surgical fol-
low-up have been reported in a
companion paper (Tonetti et al. 2004).
Subject population
Inclusion and exclusion criteria were as
previously reported (Tonetti et al. 1998,
Cortellini et al. 2001, Tonetti et al.
2002). In brief, patients younger than
21 years, with uncontrolled or poorly
controlled diabetes, unstable or life
threatening conditions, requiring anti-
biotic prophylaxis or heavy smokers
(more than 20 cigarettes/day) were
excluded (Tonetti et al. 1995). Only
patients with a diagnosis of severe
periodontitis previously treated by oral
hygiene instructions and scaling and
root planing were invited to participate.
These subjects had to present with full
mouth plaque scores (FMPS) and/or full
mouth bleeding scores (FMBS) o25%
at study baseline (following completion
of the initial periodontal treatment
phase) (Tonetti et al. 1993, Tonetti et
al. 1996). The patients were informed in
detail about the possible risks and ben-
efits and were asked to give their con-
sent to the trial. The joint ethics
committee of the Eastman Dental Insti-
tute, University College London, had
previously approved the study protocol.
Pre-treatment
All subjects received initial periodontal
therapy aimed at controlling periodontal
infection in the dentition prior to the
experimental phase. Initial treatment
consisted of patient motivation, oral
hygiene instructions and scaling and
root planing with local anaesthesia.
When indicated, clinicians supplemen-
ted mechanical debridement with anti-
septics and/or antimicrobials. Subjects
were required to present with FMPS
and/or FMBS o25% at study baseline.
At study baseline, clinical measures and
subgingival microbial samples were
obtained.
Clinical measures
Before anaesthesia, the following clin-
ical parameters were evaluated on the
day of the surgical procedure and 1 year
later. FMPS were recorded as the per-
centage of total surfaces (four aspects
per tooth) that revealed the presence of
plaque (O’Leary et al. 1972). Bleeding
on probing from the bottom of the
pocket was assessed dichotomously at




equipped with a PCP-UNC 15 tip, Hu-
friedy, Rotterdam, the Netherlands).
FMBS were then calculated.
Probing pocket depth (PPD) and reces-
sion of the gingival margin (REC) were
recorded to the nearest millimeter with a
manual pressure sensitive probe by
trained investigators at the deepest loca-
tion of the selected intrabony defect site.
All measurements were taken with a
pressure sensitive manual periodontal
probe at 0.3 N (Brodontic
s
probe
equipped with a PCP-UNC 15 tip, Hu-
friedy). Clinical attachment levels (CAL),
calculated as the sum of PPD and REC,
were the primary outcome variable.
Microbial samples
At study baseline, subgingival microbial
samples were obtained from the deepest
site in each quadrant, and in addition
from the single intrabony defect site to
be surgically treated, resulting in a total
of five plaque samples per patient. If the
intrabony defect site was also the dee-
pest site in the quadrant, then the next
deepest site was nominated as the ‘‘dee-
pest site’’ in the quadrant. Following
removal of supragingival plaque (after
evaluating FMPS but before performing
other clinical measurements), subgingi-
val plaque samples were obtained using
sterile Gracey curettes. The samples
were placed in separate Eppendorf tubes
containing 0.15 mL TE (10 mM Tris-
HCL, 1 mM EDTA, pH 7.6), and
0.15 M NaOH was added. The samples
were sent to the laboratory at the Uni-
versity of Berne, Switzerland where
they were analysed using the checker-
board DNA–DNA hybridization techni-
que for the presence and levels of 40
subgingival species (Socransky et al.
1994).
Enumeration of organisms using
‘‘checkerboard’’ DNA–DNA hybridization
The samples were lysed and neutralized
using 0.8 mL 5 M ammonium acetate.
The released DNA was placed into the
extended slots of a Minislot (Immunetics,
Cambridge, MA, USA), concentrated
onto a nylon membrane (Boehringer
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Mannheim, Indianapolis, IN, USA) by
vacuum and fixed to the membrane by
exposure to ultraviolet light (Stratalinker
1800, Stratagene, La Jolla, CA, USA).
Digoxigenin-labelled, whole genomic
DNA probes were prepared using a ran-
dom primer technique (Feinberg &
Vogelstein 1983). Forty reference bacter-
ial strains were used for the preparation of
DNA probes (Socransky et al. 1994). The
membranes were pre-hybridized at 421C
for 1 h in 50% formamide, 5  SCC, 1%
casein (Sigma, Basel, Switzerland),
5  Denhardt’s reagent, 25 mM sodium
phosphate (pH 6.5) and 0.5 mg/mL yeast
RNA (Boehringer Mannheim). Each
membrane was placed into a Miniblotter
45 (Immunetics) with the membrane
turned at 901 to its original orientation.
The probes and hybridization buffer were
placed in individual lanes of the Mini-
blotter and the whole apparatus was
placed in a sealed plastic bag. Membranes
were hybridized for 16–18 h at 421C in
a hybridizing solution containing 45%
formamide, 5  SSC, 1  Denhardt’s
reagent, 20 mM Na phosphate (pH 6.5),
0.2 mg/mL yeast RNA, 20 ng/mL of
labelled probe, 10% dextran sulfate and
1% casein. Membranes were washed at
low stringency to remove loosely bound
probe and then at high stringency (681C,
0.1  SSC, 0.1% SDS, 20 min, twice).
To detect hybrids, membranes were
blocked and incubated with a 1:20,000
dilution of anti-digoxigenin antibody
conjugated with alkaline phosphatase
using the modification described by
Engler-Blum et al. (1993). After wash-
ing, the membranes were incubated in
AttoPhos substrate (Amersham Life
Science, Arlington Heights, IL, USA)
for 16–18 h at room temperature and
signals were detected using the Storm
Fluorimager (Molecular Dynamics,
Sunnyvale, CA, USA). Two lanes of
each membrane contained standards at
concentrations of 105 and 106 cells of
each species. The sensitivity of the assay
was adjusted to permit detection of 104
cells of a given species by adjusting the
concentration of each DNA probe. Sig-
nals were evaluated using the Storm
Fluorimager and converted to absolute
counts by comparison with the standards
on the same membrane. Failure to detect
a signal was recorded as zero.
Post-surgical instructions and infection
control
Post-operative pain and oedema were
controlled with tablets of either 600 mg
ibuprofen or 500 mg acetaminophen. A
course of doxycycline 200 mg/day was
prescribed for the first post-operative
week. Patients were instructed to rinse
twice daily with 0.12% chlorhexidine
and to use modified oral hygiene proce-
dures in the treated area for the first four
post-operative weeks. They were
instructed to start gentle wiping of the
operated dento-gingival area with a
post-surgical toothbrush (Vitis Surgical,
Dentaid SA, Barcelona, Spain) soaked
in a 0.12% chlorhexidine solution from
the third post-operative day. No inter-
dental cleaning was allowed in the trea-
ted area during the first four post-
operative weeks. Smokers were asked
to limit and possibly avoid smoking.
Sutures were removed after 1 week.
Post-surgical controls and professional
tooth cleaning consisting of supragingi-
val prophylaxis with a rubber cup and
0.2% chlorhexidine gel (Plak-Out gel,
Hawe-Neos, Switzerland) were per-
formed at weeks 1, 2, 3, 4, 6 and 8.
All patients were maintained in suppor-
tive care programmes and they received
full mouth professional prophylaxis and
calculus removal at 3, 6 and 9 months as
previously detailed (Tonetti et al. 1998).
Data management and statistical analysis
Data were entered in a spreadsheet and
checked for errors. The resulting data-
base was locked and loaded in SAS
format (Statistical Application Soft-
ware, SAS Institute, Cary, NC, USA).
All calculations and analyses were per-
formed using SAS Version 8.2. Data are
expressed as means  SD. All analyses
were made using the patient as the unit
for analysis. Unbalances in the test and
control groups arising from the rando-
mization process were evaluated using
the unpaired t-test for continuous vari-
ables and the w2 test for categorical
variables. Each patient contributed one
plaque sample from the pocket at the
intrabony defect site. The significance
of differences in levels and prevalence
of the 40 tested species at the intrabony
defect sites and the deepest site in each
quadrant were determined using the
Bonferroni t-test and the Mann–Whit-
ney test. The significance of differences
at intrabony defects between smokers
and non-smokers was also determined
using the Bonferroni t-test and the
Mann–Whitney test. Significance was
set at p5 0.05 after adjusting for multi-
ple comparisons (Socransky et al. 1991).
The significance of the microbiologi-
cal parameters on the outcome variable
CAL gain was estimated by constructing
generalized linear models using the SAS
GLM procedure (Tonetti et al. 2004).
Final models were selected by elimina-
tion of non-significant factors. Model
diagnostics included distribution of
errors and analysis of residuals. The
odds of achieving a highly significant
clinical outcome (CAL gains of
43 mm) at sites colonized by high total
bacterial counts, counts of red complex
species and counts of individual red
complex species were evaluated by con-
structing logistical models that included
a treatment effect and patient- and
defect-associated covariates (Tonetti
et al. 1993, Tonetti et al. 1996, Falk et
al. 1997, Tonetti et al. 2002, Tonetti et
al. 2004). The final model was selected
with a backward elimination procedure
that allowed factors to remain in the
model whenever their significance was
p5 0.1. For all other analyses the a error
was set at 0.05.
Results
Patient retention and missing data
A total of 122 subjects were entered,
randomized and treated. During the 1
year period, two subjects were lost to
follow-up: one test and one control
patient. Complete observations were
available for 120 subjects: 61 tests and
59 controls. This represented 98.4% of
entered patients. Microbiological data
were available for 58 test and 58 control
subjects. All analyses in this report were
performed on the 116 patients with
available microbiological data.
Subject and defect characteristics at
baseline
Subject and defect characteristics at
baseline are displayed in Table 1. No
significant differences between test and
control patients were observed for any
of the subject or defect characteristics.
Baseline microbiology
Counts and proportion of bacterial com-
plexes, as described by Socransky et al.
(1998), associated with the experimental
defect are displayed in Table 2. No
significant differences were observed
between the microbiota of the intrabony
defects and the microbiota of the mouth
as assessed by the analysis of the four
deepest sites per quadrant (Fig. 1). The
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prevalence of suspected periodontal
pathogens at intrabony defect sites was
high; 68% Porphyromonas gingivalis,
45% Treponema denticola, 49% T.
socranskii, 71% Prevotella intermedia,
88% Fusobacerium nucleatum and 93%
Actinobacillus actinomycetemcomitans.
While heavy smokers (420 cigar-
ettes/day) were excluded from this
study, subjects who smoked had greater
proportions of ‘‘orange complex’’ spe-
cies identified at intrabony defect sites
compared with non-smokers (32.4 
16.7% versus 23.9  13.3%, po0.05).
Clinical Outcomes
In the control group, CAL changes
between baseline and 1 year were
2.5  1.5 mm. This was significantly
less than the CAL gain observed in the
test group, 3.3  1.7 mm (p5 0.0114,
t-test).
Table 3 shows two multivariate mod-
els, with and without microbiological
data, constructed to assess the impact
of centre, treatment and known co-
variates on the 1 year CAL gains. Total
bacterial counts had a significant
negative impact on CAL gains. Intro-
duction of total bacterial counts in
the model decreased the significance
of clinical inflammatory parameters
such as FMBS. Interestingly, inserting
total counts into the model did not
change the percentage of variability
explained by the model, suggesting
that some of the clinical parameters
may be associated with the bacterial
counts.
The impact of baseline ‘‘red com-
plex’’ counts and proportions is dis-
played in Table 4. Red complex counts
but not proportions had a significant
negative impact on 1 year CAL gains
after correcting for known covariates.
The probability of obtaining CAL
gains greater than the observed median
response (3 mm) was modeled by logis-
tic regression analyses. Bacterial para-
meters were inserted into the models
along with treatment effect, patient fac-
tors such as gender, smoking status,
FMPS and FMBS and defect factors
such as flap design, defect morphology,
depth of the intrabony component of
the defect and baseline PPD. A back-
ward elimination process was applied
setting the significance for keeping vari-
ables in the model at 0.1. The table
indicates that total counts, red complex
counts and T. forsythensis counts had a
significant but small negative effect on
the probability to gain more than 3 mm
of CAL. Counts of P. gingivalis, T.
denticola and other complexes, as well
as proportion of complexes or specific
pathogens did not have a significant
effect.
Discussion
The results of this study support the
notion that the presence of high bacterial
counts and the persistence of specific
bacterial pathogens in the pocket before
surgical treatment are negatively asso-
ciated with the outcome of treatment.
The high prevalence of A.a observed
at the intrabony defect sites within these
patients was of particular note. A series
of checks for quality control were per-
formed in order to confirm that the
signals obtained from the A.a DNA
probe used were valid. This included
cross-reactivity checks, validation of the
source DNA within the probe and run-
ning the probe against plaque samples in
healthy individuals. While the preva-
lence of A.a was considered high, simi-
lar levels have been reported in the
literature (Choi et al. 2000, Doungu-
domdacha et al. 2001, Papapanou et al.
2002).
The data are remarkable given the
high levels of plaque control and control
of clinical inflammation achieved dur-
ing a carefully performed cause-related
phase of periodontal therapy completed
to the satisfaction of the treating perio-
Table 1. Patient and defect characteristics for test and control groups at baseline (N5 116)
Variable Test Control Significance
p-value
Subject number 58 58 –
Age (years) 49.5  11.3 51  10.5 0.7424
Gender (% females) 58% 62% 0.7042
Smokers (%, o20 cigarettes/day) 36.2% 32.8% 0.6960
Antibiotic during initial therapy 44.8% 36.2% 0.3443
FMPS (%) 11.9  7 11.6  8.4 0.8289
FMBS (%) 9.4  6.9 10.6  7.3 0.3537
PPD (mm) 7.9  1.6 7.9  1.5 0.8140
CAL (mm) 9.8  1.8 10  2.2 0.6820
CEJ-BD (mm) 10.2  2.5 10.4  2.7 0.6975
Intrabony component (mm) 5.7  1.9 5.9  2.3 0.5957
Predominantly one wall (%) 22.4% 24.6%
Predominantly two walls (%) 53.5% 54.4% 0.9129
Predominantly three walls (%) 24.1% 21% n
nDefect wall morphology (Mantel–Haenszel w2).
FMPS, full mouth plaque scores; FMBS, full mouth bleeding scores; PPD, probing pocket depth;
CAL, clinical attachment levels.
Table 2. Counts and proportion of bacterial complexes associated with intrabony defect at
baseline
control (N5 58) test (N5 58) Significance, p
Bacterial counts ( 105)
Total counts 160  207 97  114 0.0433
Blue complex Actinomyces spp. 21  32 14  19 0.1368
Purple complex 10  18 6  11 0.1910
Yellow complex 14  19 8  11 0.0647
Green complex 25  31 15  19 0.0753
Orange complex 44  73 28  37 0.1827
Red complex 28  80 12  27 0.1661
Others 28  31 19  29 0.1031
Actinobacillus actinomycetemcomitans 7  14 4  5 0.0993
Proportions (%)
Blue complex Actinomyces spp. 14  17 15  16 0.7784
Purple complex 5  5 5  5 0.9636
Yellow complex 9  9 9  8 0.8597
Green complex 15  10 14  7 0.6642
Orange complex 24  12 30  18 0.0246
Red complex 15  21 10  12 0.0923
Others 19  14 17  11 0.5750
A. actinomycetemcomitans 6  8 6  6 0.7750
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dontist and meeting current clinical
practice criteria (Cortellini & Tonetti
2005). They also imply that there may
be no ‘‘clinically acceptable’’ level of
residual periodontal infection in the
context of regenerative therapy.
The deep pockets associated with the
intrabony defects treated in this study
clearly represent formidable challenges
for suppression of the periodontal
microflora and thus the high total counts
and the high prevalence of residual
pathogens observed following comple-
tion of cause related therapy are not
unexpected. In these deep pockets perio-
dontal debridement alone may not be
sufficient to properly suppress the
microbiota. Alternatively, the current
standard of practice, requiring a mini-
mum of 4–6 weeks before re-evaluation
of the outcomes of the initial, cause-
related phase of therapy, may allow
recolonization of the defect-associated
pocket with a pathogenic flora (Tonetti
et al. 1995). Such recolonization may
also occur during the healing phase
following the surgery in spite of the
meticulous post-operative regimen
using a combination of antibiotics, anti-
septics and professional tooth cleaning
(Cortellini et al. 1993).
While heavy smokers (420 cigar-
ettes/day) were excluded from this study
and thus smoking did not show a sig-
nificant effect on the clinical outcome,
the observation that subjects who
smoked had significantly greater propor-
tions of pathogens in the ‘‘orange com-
plex’’ than non-smokers may be of
importance. A detrimental effect of
smoking on the outcome of regenerative
procedures has been previously docu-
mented (Tonetti et al. 1995, Mayfield et
al. 1998, Stavropoulos et al. 2004) and
may be in part related to a more patho-
genic microflora at deep intrabony
defect sites in patients who smoke.
Given the high levels of contamina-
tion of the periodontal pockets immedi-
ately before surgery, the fact that no
frank infections leading to exfoliation
of the bone replacement graft were
observed is remarkable. Nevertheless,
clinical attachment level gains of 1 mm
or less were observed in 11% of subjects
treated with the bone replacement graft
and GTR membrane (Tonetti et al.
2004). It is conceivable that in some of
these subjects contamination of the bio-
material following manipulation and
placement in a highly contaminated
wound may be responsible for the lack
of a positive healing outcome.
Taken together with previous evi-
dence, these data support the need to
conduct intervention trials specifically
aimed at assessing the benefit(s) of
maximal suppression of the microflora














Intrabony defect sites 
Fig. 1. Pie diagrams of the percentage of the total DNA probe count of the microbial
complexes described by Socransky et al. (1998). The left pie diagram represents subgingival
plaque samples from the deepest site in each quadrant. Four sites per patient were pooled to
provide a mean value for each patient. The right pie diagram represents the subgingival
plaque samples from the intrabony defect sites (N5 116).
Table 3. Effect of baseline total bacterial counts at intrabony defect on 1 year CAL gain
Parameter Estimate Significance, p
Model without microbiological parameters (p5 0.0006, R25 0.43)
Centre (best versus worst) 1.65  0.85 0.0553
Treatment (test versus control) 0.72  0.28 0.0116
Baseline FMPS 0.05  0.03 0.0574
Baseline FMBS  0.11  0.04 0.0156
Baseline PPD 0.54  0.13 o0.0001
Model with total bacterial counts (p5 0.0002, R25 0.46)
Centre 2.15  0.82 0.0101
Treatment (test versus control) 0.62  0.28 0.0274
Baseline FMPS 0.05  0.03 0.0612
Baseline FMBS  0.09  0.04 0.0408
Baseline PPD 0.57  0.12 o0.0001
Total bacterial counts ( 105)  0.002  0.001 0.0201
FMPS, full mouth plaque scores; FMBS, full mouth bleeding scores; PPD, probing pocket depth;
CAL, clinical attachment levels.
Table 4. Effect of baseline ‘‘red complex’’ counts and proportions on 1 year CAL gain
Parameter Estimate Significance, p
Red complex counts (p5 0.0001, R25 0.47)
Centre (best versus worst) 1.8  0.9 0.0497
Treatment (test versus control) 0.71  0.28 0.0135
Baseline FMPS 0.03  0.02 0.2233
Baseline FMBS  0.08  0.04 0.0594
Baseline PPD 0.6  0.13 o0.0001
Red complex counts ( 105)  0.007  0.003 0.0114
Red complex proportions (p5 0.0014, R25 0.44)
Centre 1.8  0.9 0.0602
Treatment (test versus control) 0.8  0.3 0.0112
Baseline FMPS 0.05  0.03 0.0830
Baseline FMBS  0.12  0.05 0.0111
Baseline PPD 0.55  0.14 o0.0001
Red complex proportions 0.002  0.01 0.8661
FMPS, full mouth plaque scores; FMBS, full mouth bleeding scores; PPD, probing pocket depth;
CAL, clinical attachment levels.
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Scientific rationale for study: The
impact of the subgingival microflora
at deep intrabony defects on the
clinical attachment level gains fol-
lowing surgical/regenerative treat-
ment requires investigation.
Principal findings: High bacterial
loads and high levels of red complex
species may be found in deep intra-
bony pockets even after initial perio-
dontal therapy, and this has a nega-
tive influence on the clinical outcome
1 year following surgical /regenera-
tive treatment.
Practical implications: Additional
antimicrobial treatment may be
required prior to regeneration at
intrabony defects to reduce bacterial
load. Prospective intervention trials
to establish the benefit(s) of maximal
pre-operative microbial suppression
are needed.
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